During the past decade, The Second Hospital of Dalian Medical University conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 1 clinical trials were completed. i.e. 4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Hospital of Dalian Medical University" #1 sponsor was "The Second Affiliated Hospital of Dalian Medical University" with 5 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 4 trials sponsored, "BeiGene" with 3 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored and "Fudan University" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Hospital of Dalian Medical University" #1 collaborator was "The Second Affiliated Hospital of Dalian Medical University" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Beijing Shijitan Hospital Affiliated to Capital Medical University" with 1 trials as a collaborator and "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "The Second Hospital of Dalian Medical University" are "Breast Cancer" (5 trials), "Hyperphosphatemia" (2 trials), "Macular Edema" (2 trials), "Postoperative Complications" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "The Second Hospital of Dalian Medical University" in a lesser frequency.

Most popular intervention types in "The Second Hospital of Dalian Medical University" are "Drug" (38 trials), "Other" (7 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anlotinib" (2 trials), "Carboplatin" (2 trials), "Cyclophosphamide" (2 trials), "Etoposide" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Second Hospital of Dalian Medical University" are 43 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Second Hospital of Dalian Medical University". undefined are not yet recruiting, 17 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in The Second Hospital of Dalian Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Hospital of Dalian Medical University, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".